{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is RVL Pharmaceuticals Plc technically bullish or bearish?
As of November 25, 2024, the trend is mildly bearish due to daily moving averages, despite mixed signals from weekly and monthly indicators, suggesting caution in trading.
Who are in the management team of RVL Pharmaceuticals Plc?
As of March 2022, the management team of RVL Pharmaceuticals Plc includes Mr. Brian Markison (Chairman and CEO), Mr. Joachim Benes, Mr. David Burgstahler, Mr. Sriram Venkataraman, Mr. Juan Vergez, and Mr. Gregory Cowan (Independent Director). They oversee the company's operations and strategic direction.
How big is RVL Pharmaceuticals Plc?
As of Jun 18, RVL Pharmaceuticals Plc has a market capitalization of 0.00, classifying it as a Micro Cap company. For the latest four quarters, it reported net sales of 36.92 million and a net profit of -68.27 million, with shareholder's funds of 51.09 million and total assets of 135.38 million as of Dec 22.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
